Mice that received an intratumoral injection of the hAds showed an increase of only TNF-α expression, which naturally precedes IL-6 [46, 48], suggesting that anatomical barriers such as the tight junction between tumor cells may have reduced the path of the viral vector delaying the elicitation of innate immunity. The gene discussed is IL6; the disease is neoplasm.